Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01582828

Serial Hybrid Atrial Fibrillation Ablation

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Medisch Spectrum Twente · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Treatment of (long-standing) persistent atrial fibrillation (AF) remains cumbersome and the surgical (epicardial) approach seems to be the most effective. Still, however a significant amount of failures exist which is mostly due to incompleteness of the surgical ablation lines. Checking, and if necessary additional ablation, of these lines afterwards endocardially by the cardiologist (the so-called serial hybrid approach) could overcome this problem.

Conditions

Interventions

TypeNameDescription
PROCEDUREEpicardial (surgical) ablation* Pulmonary vein isolation with bipolar clamps and bipolar box lesion * Epicardial atrial appendage closure
PROCEDUREHybridEpicardial (surgical) ablation * Pulmonary vein isolation with bipolar clamps and bipolar box lesion * Epicardial atrial appendage closure Endocardial assessment after 6-8 weeks, checking for isolation and if necessary touch up by RF ablation

Timeline

Start date
2012-08-01
Primary completion
2016-12-01
Completion
2017-12-01
First posted
2012-04-23
Last updated
2024-11-22

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT01582828. Inclusion in this directory is not an endorsement.